Physiologically based pharmacokinetic modeling of CYP2C8 substrate rosiglitazone and its metabolite to predict metabolic drug-drug interaction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Physiologically based pharmacokinetic modeling of CYP2C8 substrate rosiglitazone and its metabolite to predict metabolic drug-drug interaction

Published:2024-08 Issue: Volume:57 Page:101023
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Gaud Nilesh^ORCID,Gogola Dawid,Kowal-Chwast Anna^ORCID,Gabor-Worwa Ewelina^ORCID,Littlewood Peter,Brzózka Krzysztof,Kus Kamil^ORCID,Walczak Maria^ORCID

Publisher

Elsevier BV

Reference33 articles.

1. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective;Jones;Clin Pharmacol Therap,2015

2. Usage of in vitro metabolism data for drug-drug interaction in physiologically based pharmacokinetic analysis Submissions to the US food and drug administration;Lee;J Clin Pharmacol Jun,2021

3. Physiologically based pharmacokinetic modeling in regulatory science: an update from the U.S. Food and drug administration’s office of clinical Pharmacology;Grimstein;J Pharmaceut Sci,2019

4. Quantitative rationalization of gemfibrozil drug interactions: consideration of transporters-enzyme interplay and the role of circulating metabolite gemfibrozil 1-O-b-Glucuronide;Varma;Drug Metabol Dispos,2015

5. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy;Scott Obach;Pharmacol Rev,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3